We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
York Pharma | LSE:YRK | London | Ordinary Share | GB00B00QHC86 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/8/2008 09:05 | Dipped back in NMS limiting buys to 5000 shares | ch1ck | |
31/7/2008 19:13 | "We are very grateful to shareholders...' Hmm... Sounds like someone had Terry by the nuts!! | wetdream | |
26/7/2008 18:24 | No, all gone. | topvest | |
25/7/2008 14:08 | Bark Pharma! | awe430save132 | |
25/7/2008 12:22 | topvest, do you still hold any YRK? | wetdream | |
24/7/2008 21:28 | But could have made more, if I had sold them all earlier! Clock is ticking on Terry's plan now I'm afraid which is a real shame. Without Abasol approval this won't move forward. Latest acquisition looks like it may have fallen through, in which case they will be running low on cash. | topvest | |
24/7/2008 21:28 | but u have got to remember every dog has its day i will top up on further weakness dyor as always | m4p | |
19/7/2008 20:39 | think i wiil top up dyor | m4p | |
18/7/2008 20:47 | OOPS...looks like they are having problems raising the money now the share price has fallen. | topvest | |
09/7/2008 19:37 | Thanks Nobby great post | m4p | |
08/7/2008 21:56 | >> topvest I have to say that I also noticed that it said 'decision' in one place in the interim results. However, in the operational highlights at the beginning it says 'marketing approval' so I don't think we have anything to worry about. Also the fact that banks have lent them money in a very difficult credit market to me is very reasuring. I cannot believe that any institution would have given them money without being assured that Abasol was going to be approved. After all Abasol is rather a major part of the business plan going forward in the short term. During your interactions with the regulator you get a pretty good idea of how it is going. For what its worth, I also can't believe it would have taken this long if the MHRA were going to reject it. What has happened here is that we have an approvable drug but a file which was not of good quality. This is not surprising because it is difficult even for medium to big companies to put together the information required let alone a small outfit like YRK. So as I've said before 'patience is a virtue' is a saying made for YRK. However, I think approval will finally come in the near future. Nobby | nobbygnome | |
07/7/2008 09:20 | I'm disappointed to say that I've sold all of my York Pharma shares - bought mine at 25p and 50p, and this is my second disposal so I've made a reasonable profit. I've sold because of 2 reasons: - The latest acquisition has been funded by debt which is precisely what Terry said he wouldn't do following Bioglan; - The Abasol statements look like it's going to be a negative decision to me. Talk about a decision in H2 rather than a approval in H2 - suggests to me that all is not well. Good luck to those that remain, but my patience has finally run out after 4 years. Better to quit while I'm ahead (just!) in today's market. | topvest | |
07/7/2008 07:25 | Kiki The warrants are a complete punt in that you either lose the lot or make a fortune. So the downside is just 100% but the upside I would suggest is upwards of 1000%. To me that is a very good risk reward ratio especially now that we have a company which is essentially self sustaining. The approval of Abasol will clearly produce the really big win. Nobby | nobbygnome | |
06/7/2008 23:45 | few more for me old bioshark :-) just can't help myself it would be rude not to buy more | m4p | |
06/7/2008 15:09 | Thanks Nobby, interesting to hear your thoughts. With the markets as they are I think there will still be good opportunities to add at these prices but IMHO offer exceptionally good value. I may be looking to add a few more this week. Nobby, the warrants look possible of sizeable increases but expire in February 2009, I guess if you think Abasol will be approved and licensing deals announced before then they are a very good bet. | kiki14p |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions